Aims: To determine if tumors located in the subcapsular space or in proximity to vessels would be a risk factor of local tumor progression (LTP 2 ) in hepatocellular carcinomas (HCC) after radiofrequency ablation.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer around the world [1] and is the third most common cause of cancer--related death worldwide [2] . The management of HCC is multi-disciplinary and includes liver resection, transplantation and loco-regional therapies, of which percutaneous radiofrequency ablation (RFA) is becoming increasingly essential especially for small HCC. RFA is a less invasive and simpler therapeutic modality, requiring shorter hospitalizations but a similar prognosis compared with surgical treatment [3, 4] . For these reasons, RFA has been a first-line curative treatment for HCC especially early-stage hepatocellular carcinoma according to the Barcelona Clinic Liver Cancer (BCLC) strategy [5] . However, tumor recurrence after ablation remains a major problem similar to surgical treatment, and local tumor progression (LTP) is a specific recurrence type that seriously jeopardizes the chance of cure and results in retreatment RFA with a high risk of failure [6, 7] .
LTP describes the appearance of tumor foci at the edge of the ablation zone after at least one contrast-enhanced follow-up study has documented adequate ablation [8] . The reported LTP rates after RFA ranged from 2 to 60% [7, 9, 10] , which occupied 6.8%-22.8% in overall recurrence [2, 4, 11] . Tumor location might have a great influence on patients' prognosis after RFA. When tumors are subcapsular and subphrenic, it might result in poor visibility and difficulty in US guidance. When tumors are subcapsular and abutting vital organs such as the heart or stomach, it might a cause reduction of energy application [12] . When tumors are non-subcapsular but next to vessels, it might decrease heat accumulation and result in "heat-sink" effect [13] [14] [15] . All three specific tumor location have an impact on ablation effectiveness. The 16 studies which we included had researched the impact of specific tumor locations, but their results differed from each other. Therefore, this systematic review and meta-analysis aims to authenticate the relationship between specific tumor locations and LTP, with an emphasis on subcapsular and vessels-abutting locations.
Materials and methods
A search of the MEDLINE, EMBASE and Cochrane Library databases from 1998 to 2017 was performed using the following strategy: "Hepatocellular Carcinoma" as a MeSH term and a "Risk Factors", "Prognosis", "radiofrequency ablation" and "local tumor progression" as the free terms, along with their common variations. No language or other restrictions were imposed.
Studies would be included if the following criteria were met: (1) clinical studies including patients taking RFA as the initial treatment for HCC without previous treatment history or combined therapies or. (2) data of the association between specific tumor location and LTP was reported. Studies were excluded if either of the following exclusion criteria were met: (1) case report or (2) follow-up time < 12 months. A literature flow diagram is depicted in Fig. 1 .
All search results were evaluated by two reviewers (Z.C.L and H.T.H) by scanning the relevant title and abstract. Potentially eligible citations from the retrieved articles were reviewed to identify additional studies. NOS (Newcastle-Ottawa scale) was used to evaluate the level of evidence. Disagreements between the two reviewers regarding study selection and quality assessment were resolved through discussion with the third reviewer (W·W).
The two reviewers (Z.C.L and H.T.H) who performed the initial literature search independently extracted the relevant data with a standardized form that included information about the study design characteristics and examination results. Reviewers were not blinded to the authors' affiliations or the journal name [16] . All disagreements were resolved through discussion with the third reviewer (W.W).
The following basic parameters from the included studies were extracted: basic information of studies (such as authors, publication year, region where the study was performed), patient characteristics (gender, age, the mean number and size of tumors, patients with hepatitis B or C virus infection and liver function, level of AFP and the follow-up period), relevant information about the research object and clinical outcome (Odds Ratio). Data were extracted directly or transferred from the original data into 2 × 2 tables.
Statistical analysis
The Odds Ratio (OR) or Risk Ratio (RR) of LTP were determined, the significance of which was determined by Z-test; P < 0.05 was considered statistically significant. I 2 statistics were used to evaluate heterogeneity. In general, high heterogeneity was considered with P < 0.1 or I 2 > 50%, and the random effects model was used [17] .
Otherwise, the fixed effects model was use. Meta-regression was performed to reveal possible heterogeneity sources. Subgroup analyses were performed based on the regression results. All of the data analysis was completed using the software program Reviewer Manager 5.3 (Cochrane Collaboration, Oxford, UK).
Results
The literature search yielded a total of 1729 studies, of which 211 studies were potentially relevant based on the title and abstract. After the full-text was reviewed, there were not clear definitions of LTP in 28 studies and no relevant outcomes about the risk factors of LTP in 167 studies. Finally, 16 articles were included; the result of relationship between LTP and tumor locations in terms of the proximity to vessel was included in 7 studies and the relationship between LTP and the subcapsular space in 15 studies.
There was a prospective randomized trial and a prospective cohort study, and the majorities were case-control studies. NOS scores of included studies were 6-8 (Supplementary materials). In total, 2870 patients were included and the male to female ratio was 2.36:1. The average age of the patients ranged from 54 to 69, and the follow-up period ranged from 16.0 ± 4.3 months to 55.7 ± 12.3 months. The mean number of tumors per patient in the selected studies ranged from 1.0 to 3.67, and the average diameter of tumors varied from 14.8 ± 3.8 mm to 26.0 ± 10.2 mm. The percentage of patients with Child-Pugh grade A or B ranged from 82.3% to 100%, and the percentage with hepatitis virus B or C ranged from 77.9% to 93.3%. The included studies' characteristics are presented in Table 1 .
Most included studies did not clearly distinguish subphrenic-subcapsular location and abutting-vital-organs subcapular location. We obtained a summary result of 15/16 studies that reported the tumor location as "subcapsular" or abutting specific organs. The summary original results of included studies are presented in Table 2 . The results indicated a significant association between LTP and subcapsular location (OR, 1.64, 95%CI 1.01 to 2.65, P = 0.04) (Fig. 2) . However, a high heterogeneity (I 2 = 65%) was also indicated. We performed a metaregression, which revealed no source of heterogeneity from the region, the mean tumor number or size, etiology, liver function or the follow-up period. The results of the 7 studies that mentioned the relationship between tumors adjacent to vessels and LTP indicated a non-significant result (OR, 2.12, 95%CI 0.99 to 4.56, P = 0.05) (Fig. 3) . Similarly, these results had a high heterogeneity (I 2 = 77%). In the sub-group analyses, no significant results were indicated for tumors abutting the hepatic vein (P = 0.53) (Fig. 4) or portal vein (P = 0.40) (Fig. 5 ).
Discussion
This meta-analysis included 16 retrospective studies and 2870 patients. The summary results indicated that tumors of subcapsular location had a higher risk of LTP, but tumors in close proximity to vessels did not have a higher risk. Since the included studies did not clearly define subcapsular location tumors, we could not inspect the association between LTP and the specific "subcapsular" location such as subphrenic or abutting vital organs. With a limited number of studies reporting tumor location as proximity to vessels and the high heterogeneity, we could not reach a firm conclusion about the association of this location with LTP. We have already recognized that tumor recurrence was due to viable cancer cells being sheltered in necrotic zones [18] , which usually depended on the ablation margin [19] [20] [21] . One of the reasons for performing RFA without an insufficient ablation margin is that tumors could be located in the subcapsular area or in close proximity to vessels. For example, subcapsular HCC (right lobe of liver) such as tumors located under the diaphragm were invisible or poorly visible on US, which increased the technical difficulty of adequate placing of the electrodes [5] , increasing the difficulty for operators to obtain sufficient ablation margins. In addition, subcapsular HCC (close to vital organs) is usually ablated with limited therapeutic doses due to fear of collateral heat injury to surrounding organs such as the gastrointestinal tract, abdominal wall and diaphragm [22] . On the other hand, better tumor visibility has the benefit of providing sufficient ablation margins. As a widely applied technique, real-time US-CT/MR fusion imaging had better tumor visibility and technical feasibility, which contributed to decreasing the occurrence of LTP [23, 24] . Our results revealed that the location of subcapsular might be a risk factor of LTP. However, our results showed a high heterogeneity and we could not identify the source of heterogeneity. We thought the heterogeneity might be connected to the fact that there was no clear definition or classification of subcapsular so far, which could also explain the controversial results of previous studies. More studies that include a specific definition or classification of subcapsular should be performed if we want to authenticate the influence of tumor visibility and risk location on LTP.
At the same time, the heat-sink effect was also an important cause of the increased occurrence of LTP for those tumors located adjacent to vessels. However, a contrary result we reached had been weighed in our meta-analysis. There are several potential factors affecting the discrepancy between our findings and previous studies. Race might be a potential factor requiring consideration and should not be ignored. Of the limited number of studies, patients come mainly from Asian countries. Furthermore, in the study by Kim [13] , there was a clear restriction for the diameter of the large vessel. Vessels over 3 mm would be allowed to be included in the study. However, the 7 studies that we included did not have the similar restriction for the diameter of the vessel, which became an important difference on the quality of research objects. Taking these studies for example, the classification and diameter of vessels they studied were not standardized and their results tended to be paradoxical [11, 12, 25] . However, we thought there was another reason because most of the patients we studied had liver cirrhosis from hepatitis B. The cirrhosis tissue around the tumor might behave similar to thermal insulator, increasing the heat retention within the tumor and preventing heating outside the tumor [26] , which decreased the influence of heat-sink and increased the thermal accumulation to kill the cancer cells. Therefore, we think our results were controversial and there was insufficient evidence to reach a firm conclusion. More studies that have similar restriction on the classification and diameter of vessels and similar races and etiology of patients should be performed. Our study has some limitations. First, there were no cohort studies or randomized controlled studies in the included studies, most of which were of the case-control design. Additionally, none of the trials blinded the treatment providers because of the nature of the international operation. Therefore, inherent selection bias was unavoidable and the accuracy of the outcomes would be affected [27, 28] . Second, a small number of relevant studies were included, which might have led to false-negative or false-positive conclusions. In particular, only 7 studies were used for analysing if tumors located adjacent to vessels were related to an increase opportunity of LTP. Third, the varied patient characteristics such as the mean number and size of tumors, patients with hepatitis B or C virus infection and liver function and the follow-up period might limit the accuracy of the pooled data. Sixth, the Odds Ratio of some studies is transferred from Risk Ratio because of the lack of original data, so some error is inevitable. Nevertheless, the Cochrane Collaborative Group recommends that not all data need to be perfectly accurate when some patient data are lacking [29] .
A number of credible techniques were used to reduce the potential bias, such as an extensive search of the literature, strict guidelines regarding duplicate data extraction, the use of clear criteria, and the use of a random effects model for estimation and contacting the corresponding authors by e-mail. Despite the above-described limitations, this meta-analysis provides the latest research in determining the relationship of risk locations and LTP.
Conclusion
The findings of the present meta-analysis indicate that a location of subcapsular is a possible risk factor of LTP. Nevertheless, a clear definition or classification of subcapsular should be highlighted in future studies, which helps to make clear the clinical importance. At the same time, whether tumors located adjacent to a vessel have an influence of the incidence of LTP remains controversial. Considering the difference of patients' characteristics, the small number and the study type of the included studies, there is unavoidable error in our results, and more studies that are similar in study type and patients' characteristic should be performed to authenticate or support our conclusions.
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